Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2a Study of the Effect of Serine Supplementation and Fenofibrate Treatment on Serum Deoxysphinganine Levels in Patients With Macular Telangiectasia (MacTel) Type 2 (SAFE Study)

NCT04907084 is registered in ClinicalTrials.gov with The Lowy Medical Research Institute Limited as lead sponsor.

NCT NCT04907084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04907084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2a Study of the Effect of Serine Supplementation and Fenofibrate Treatment on Serum Deoxysphinganine Levels in Patients With Macular Telangiectasia (MacTel) Type 2 (SAFE Study)
Lead sponsor
The Lowy Medical Research Institute Limited
Phase
Phase 2
Overall status
Completed
Start date
April 7, 2022
Completion date
September 30, 2024
Enrollment
89 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

macular telangiectasia type 2